Impact of Antimicrobial Stewardship Programs in the Global Setting
NCT ID: NCT03382470
Last Updated: 2019-07-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3115 participants
OBSERVATIONAL
2018-03-12
2019-03-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Antibiotic Stewardship in Small Hospitals
NCT03245879
Efficacy and Cost-effectiveness of Hospital Antimicrobial Stewardship Programs
NCT02814877
Antimicrobial Stewardship in Community Hospitals
NCT02212808
The Impact of an Antimicrobial Utilization Program on Antimicrobial Use
NCT00552838
Antimicrobial Stewardship Interventions in a Hospital Setting
NCT04001309
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Antimicrobial stewardship advice
A basic antimicrobial stewardship team will be created at each site. The team will provide advice on the treatment of urinary tract infections and asymptomatic bacteriuria during the second half of the study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Moi University
OTHER
Kilimanjaro Christian Medical Centre, Tanzania
OTHER
Ruhuna University, Sri Lanka
UNKNOWN
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gayani Tillekeratne, MD MSc
Role: PRINCIPAL_INVESTIGATOR
Assistant Professor of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Teaching Hospital Karapitiya
Galle, , Sri Lanka
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00089077
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.